Assessing diabetes and pre-diabetes prevalence in Réunion Island
Official title: Study of the Prevalence of Diabetes and Pre-diabetes in Réunion Island
Run by Centre Hospitalier Universitaire de la Réunion · NCT06473584 · Data updated 2026-11-12
This study is trying to find out how common diabetes and pre-diabetes are in Réunion Island and what factors might put people at risk for these conditions.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | Centre Hospitalier Universitaire de la Réunion Academic / other |
| Locations | 1 site (Saint-Denis) |
| Status | Recruiting |
| Started | April 2, 2025 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 14, 2026 |
| Trial ID | NCT06473584 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 18 to 75 who have lived in Réunion Island for at least one year and are affiliated with a social security scheme.
✕Probably not a fit
Patients who do not reside in Réunion Island for at least one year, are pregnant, or do not understand French may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to gather current data on the prevalence of diabetes and pre-diabetes in Réunion Island as part of a regional initiative to combat these conditions. It focuses on identifying risk factors such as age, obesity, and family history using the Findrisk score, which has been validated in other populations. The study will measure these risk indicators to ensure that the thresholds for diabetes risk are appropriate for the unique population characteristics of Réunion. Participants will undergo diabetes detection interventions to facilitate this assessment.
Why it matters
Potential benefit: If successful, this study could lead to improved identification and management of diabetes and pre-diabetes in the Réunion population.
How similar studies have gone: While the approach of using the Findrisk score has been validated in Finland, this specific application in Réunion Island is novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Have lived in Réunion island for at least one year * Be aged between 18 and 75 * Affiliated to or benefiting from a social security scheme * Free, informed and signed consent Exclusion Criteria: * No main residence on the island or fixed address for at least one year on the island * Participation in experimental research * Pregnant women * Adults under guardianship or legal protection * Not understanding French
Where it's running
-
CHU La Réunion
Saint-Denis, Reunion Recruiting
Study contacts
- Principal investigator: Catherine MARIMOUTOU, MD, PhD — CHU La Réunion
- Study coordinator: Catherine MARIMOUTOU, MD, PhD
- Email: catherine.marimoutou@chu-reunion.fr
- Phone: +262 (0)262 90 50 50
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
Benefits of Retained Insulin for Good Health in Diabetes
This study tests whether preserving or restoring a person’s own insulin production can improve quality of life and blood sugar control for people who need insulin to manage diabetes.
-
Improving Care for underserved older Black patients with cardiovascular and other chronic conditions
This study tests a culturally tailored approach to patient-centered care for older African American patients with cardiovascular disease and other conditions who receive care at a community hospital.
-
Myokines in metabolic and endocrine diseases linked to sarcopenia
This study tests whether myokines can serve as biomarkers or drivers of sarcopenia and sarcopenic obesity in people with metabolic or endocrine diseases.
-
Miniature breath sensors to detect hypo- and hyperglycemia in young people with diabetes
A small breath-sensor device will try to see if specific breath compounds can signal low or high blood sugar in youths with diabetes.
-
Polypill Approach for Multiple Cardiovascular Risk Factors
Researchers are testing a fixed-dose pill strategy to help people aged 50–75 with high blood pressure, high cholesterol, and diabetes see if it lowers their heart-disease risk and reduces future events.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.